Toth Financial Advisory’s Ascendis Pharma A/S ASND Stock Holding History

Toth Financial Advisory’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1M	Sell	4,830 -1,050	-18%	-$266K	0.11%	132
2026 Q2	$1.57M	Buy	5,880 +430	+8%	+$100K	0.15%	121
2026 Q1	$1.25M	Buy	5,450 +810	+17%	+$182K	0.14%	122
2025 Q4	$989K	Buy	4,640 +4,045	+680%	+$835K	0.11%	134
2025 Q3	$118K	Buy	595 +150	+34%	+$28K	0.01%	252
2025 Q2	$76.8K	Sell	445 -4,890	-92%	-$797K	0.01%	269
2025 Q1	$832K	Buy	+5,335	New	+$762K	0.1%	135

Other funds holding ASND

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Toth Financial Advisory's ASND Position: Q3 2026 in Review

Toth Financial Advisory reduced its Ascendis Pharma A/S (ASND) stake by 18% in Q3 2026, selling an estimated $266K and leaving 4,830 shares worth $1.1M. The position accounts for 0.11% of the portfolio, ranked #132.

Toth Financial Advisory first reported a position in ASND in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.57M in Q2 2026. 34 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Toth Financial Advisory held 4,830 shares of Ascendis Pharma A/S worth $1.1M as of Q3 2026.
Toth Financial Advisory sold 1,050 Ascendis Pharma A/S shares in Q3 2026, an estimated $266K.
Ascendis Pharma A/S made up 0.11% of Toth Financial Advisory's portfolio in Q3 2026, its #132 holding.
Toth Financial Advisory first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 7 quarters since.
Toth Financial Advisory's Ascendis Pharma A/S position peaked at $1.57M in Q2 2026.
34 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.